Schizophrenia associated gene, proteins and biallelic markers
US6555316B1 · kind B1 · utility
10Cited by
0References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2000 |
| Grant date | Apr 29, 2003 |
| Priority date | — |
| Expiry date | Oct 3, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/172
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention concerns the human g35030 gene, polynucleotides, polypeptides biallelic markers, and human chromosome 13q31-q33 biallelic markers. The invention also concerns the association established between schizophrenia and bipolar disorder and the biallelic markers and the g35030 gene and nucleotide sequences. The invention provides means to identify compounds useful in the treatment of schizophrenia, bipolar disorder and related diseases, means to determine the predisposition of individuals to said disease as well as means for the disease diagnosis and prognosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.